Global Medical REIT Inc. (NYSE:XRN – Get Free Report) CEO Mark Okey Decker, Jr. acquired 5,000 shares of the stock in a transaction that occurred on Tuesday, May 12th. The stock was purchased at an average price of $33.94 per share, with a total value of $169,700.00. Following the transaction, the chief executive officer owned 59,774 shares in the company, valued at $2,028,729.56. This represents a 9.13% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Global Medical REIT Trading Up 1.7%
Global Medical REIT stock traded up $0.57 during mid-day trading on Tuesday, hitting $34.11. 422,301 shares of the company’s stock were exchanged, compared to its average volume of 119,647. The company’s 50 day simple moving average is $35.08 and its 200-day simple moving average is $34.42. The company has a quick ratio of 0.61, a current ratio of 0.61 and a debt-to-equity ratio of 1.62. The firm has a market capitalization of $451.21 million, a P/E ratio of -30.73 and a beta of 1.11. Global Medical REIT Inc. has a fifty-two week low of $29.05 and a fifty-two week high of $39.93.
Global Medical REIT Dividend Announcement
The firm also recently announced a monthly dividend, which will be paid on Friday, September 18th. Investors of record on Thursday, August 20th will be paid a dividend of $0.16 per share. This represents a c) dividend on an annualized basis and a yield of 5.6%. The ex-dividend date of this dividend is Thursday, August 20th. Global Medical REIT’s dividend payout ratio is presently -270.27%.
Hedge Funds Weigh In On Global Medical REIT
Wall Street Analyst Weigh In
A number of brokerages recently issued reports on XRN. Weiss Ratings lowered Global Medical REIT from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday. Wall Street Zen cut Global Medical REIT from a “hold” rating to a “sell” rating in a report on Saturday. Finally, Compass Point reissued a “neutral” rating and set a $38.00 price target (down from $50.00) on shares of Global Medical REIT in a research report on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $39.67.
Check Out Our Latest Research Report on Global Medical REIT
Global Medical REIT Company Profile
Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.
Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.
Featured Articles
- Five stocks we like better than Global Medical REIT
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
- The Event That Could Redefine Apple’s Summer Rally
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.
